Skip to content
1887

Microbial Genomics logo Microbial Genomics

Volume 11, Issue 11

Population snapshot of causing invasive disease among adults aged ≥18 years in South Africa before and after implementation of pneumococcal conjugate vaccines in 2005–2020 Open Access

Abstract

Routine use of pneumococcal conjugate vaccines (PCV) in South Africa caused a decline in vaccine-associated invasive pneumococcal disease (IPD), followed by the emergence of non-PCV serotypes, driven mainly by pre-existing lineages. We determined the molecular epidemiology of isolates causing IPD among adults in South Africa from 2020 to 2025 before and following the implementation of PCV in 2009. We performed whole-genome sequencing on randomly selected isolates causing IPD among adults aged ≥18 years (=1 581) during the four vaccine periods [pre-PCV (2005–2008), PCV7 (2009–2010), early-PCV13 (2011–2014) and late-PCV13 (2015–2020)]. We assigned serotype, multi-locus sequence type, clonal complex (CC) and global pneumococcal sequence cluster (GPSC) and determined antimicrobial non-susceptibility profiles . Poisson regression was used to calculate incidence rate ratios of imputed individual GPSC lineages using IPD incidence rate estimated per year for the three vaccine periods (PCV7, early-PCV13 and late-PCV13), compared to the pre-PCV period. Overall, our dataset represented 3.7% (=270), 3.4% (=128), 4.9% (=287) and 13.5% (=896) of adult pneumococcal isolates received during the four periods, respectively. We identified 135 GPSCs with the majority of isolates [68.7%(1 086/1 581)] clustering into 1 of 23 dominant GPSCs defined as GPSCs that comprised ≥20 genomes in the dataset. Compared to the pre-PCV7 period, a decrease in incidence of vaccine type lineages normally associated with vaccine serotypes was observed during the late-PCV13 period. GPSC2 (serotype 1) declined from 1.4 to 0.039/100,000 population (<0.001). Some non-PCV lineages increased. GPSC26 (serotype 12F) increased from 0.07 to 0.3 (<0.001). Of the 23 dominant GPSCs, 11 expressed ≥2 serotypes. While the majority of GPSC5/CC172 isolates expressed serotype 23F during the pre-PCV period (61.5%, 7/12), serotype 35B was the most common serotype (57.1%, 12/21) expressed by GPSC5/CC172 isolates during the late-PCV13 period. All GPSC9/CC63 isolates sequenced from the pre-PCV period (=3) expressed serotype 14; however, during the late-PCV13 period, nearly all (88.2%, 15/17) were serotype 15A. The emergence among non-PCV13 serotypes, of lineages usually associated with PCV13 serotypes (such as GPSC5/CC172 and GPSC9/CC63), warrants continued genomic surveillance in South Africa, more so as PCV10 (Pneumosil) replaced PCV13 in South Africa in 2024.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): global pneumococcal sequence cluster (GPSC) , pneumococcal conjugate vaccine (PCV) and pneumococcus
Funding
This study was supported by the:
  • Fleming fund
    • Principal Award Recipient: Annevon Gottberg
  • Fogarty International Center Global Infectious Disease (Award D43TW011255)
    • Principal Award Recipient: KediboneMaria Ndlangisa
  • Bill and Melinda Gates Foundation (Award INV-003570)
    • Principal Award Recipient: Annevon Gottberg
  • Pfizer South Africa (Award WS116752 (1))
    • Principal Award Recipient: Annevon Gottberg
  • U.S. President’s Emergency Plan for AIDS Relief (Award U62/CCU022901)
    • Principal Award Recipient: Annevon Gottberg
© 2025 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.001559
2025-11-19
2025-12-16

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/mgen/11/11/mgen001559.html?itemId=/content/journal/mgen/10.1099/mgen.0.001559&mimeType=html&fmt=ahah

References

  1. von Gottberg A, de Gouveia L, Tempia S, Quan V, Meiring S et al. Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med 2014; 371:1889–1899 [View Article]
     [Google Scholar]
  2. Whitney CG. Impact of conjugate pneumococcal vaccines. Pediatr Infect Dis J 2005; 24:729–730 [View Article] [PubMed]
     [Google Scholar]
  3. Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005; 294:2043 [View Article]
     [Google Scholar]
  4. Liyanapathirana V, Nelson EAS, Ang I, Subramanian R, Ma H et al. Emergence of serogroup 15 Streptococcus pneumoniae of diverse genetic backgrounds following the introduction of pneumococcal conjugate vaccines in Hong Kong. Diagn Microbiol Infect Dis 2015; 81:66–70 [View Article] [PubMed]
     [Google Scholar]
  5. Martin JM, Hoberman A, Paradise JL, Barbadora KA, Shaikh N et al. Emergence of Streptococcus pneumoniae serogroups 15 and 35 in nasopharyngeal cultures from young children with acute otitis media. Pediatr Infect Dis J 2014; 33:e286–90 [View Article] [PubMed]
     [Google Scholar]
  6. Sheppard C, Fry NK, Mushtaq S, Woodford N, Reynolds R et al. Rise of multidrug-resistant non-vaccine serotype 15A Streptococcus pneumoniae in the United Kingdom, 2001 to 2014. Euro Surveill 2016; 21:1–10 [View Article] [PubMed]
     [Google Scholar]
  7. Beall B, McEllistrem MC, Gertz RE Jr, Wedel S, Boxrud DJ et al. Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002. J Clin Microbiol 2006; 44:999–1017 [View Article] [PubMed]
     [Google Scholar]
  8. Janoir C, Lepoutre A, Gutmann L, Varon E. Insight into resistance phenotypes of emergent non 13-valent pneumococcal conjugate vaccine type pneumococci isolated from invasive disease after 13-valent pneumococcal conjugate vaccine implementation in France. Open Forum Infect Dis 2016; 3:ofw020 [View Article] [PubMed]
     [Google Scholar]
  9. Olarte L, Kaplan SL, Barson WJ, Romero JR, Lin PL et al. Emergence of multidrug-resistant pneumococcal serotype 35B among children in the United States. J Clin Microbiol 2017; 55:724–734 [View Article]
     [Google Scholar]
  10. Boyles TH, Brink A, Calligaro GL, Cohen C, Dheda K et al. South African guideline for the management of community-acquired pneumonia in adults. J Thorac Dis 2017; 9:1469–1502 [View Article] [PubMed]
     [Google Scholar]
  11. Von Gottberg A, Kleynhans J, de Gouveia L, Tempia S, Meiring S et al. Long-term impact of pneumococcal conjugate vaccines from national, active, laboratory-based surveillance of invasive pneumococcal disease, South Africa, 2005-2019. Lancet Glob Health 2024; 12e1470–e1484 [View Article]
     [Google Scholar]
  12. Ndlangisa KM, du Plessis M, Wolter N, de Gouveia L, Klugman KP et al. Population snapshot of Streptococcus pneumoniae causing invasive disease in South Africa prior to introduction of pneumococcal conjugate vaccines. PLoS One 2014; 9:e107666 [View Article] [PubMed]
     [Google Scholar]
  13. Lekhuleni C, Ndlangisa K, Gladstone RA, Chochua S, Metcalf BJ et al. Impact of pneumococcal conjugate vaccines on invasive pneumococcal disease-causing lineages among South African children. Nat Commun 2024; 15:8401 [View Article] [PubMed]
     [Google Scholar]
  14. Huebner RE, Klugman KP, Matai U, Eggers R, Hussey G et al. Laboratory surveillance for Haemophilus influenzae type B meningococcal, and pneumococcal disease. Haemophilus Surveillance Working Group. S Afr Med J 1999; 89:924–925 [PubMed]
     [Google Scholar]
  15. da Gloria Carvalho M, Pimenta FC, Gertz RE Jr, Joshi HH, Trujillo AA et al. PCR-based quantitation and clonal diversity of the current prevalent invasive serogroup 6 pneumococcal serotype, 6C, in the United States in 1999 and 2006 to 2007. J Clin Microbiol 2009; 47:554–559 [View Article]
     [Google Scholar]
  16. Wasas AD, Huebner RE, De Blanche M, Klugman KP. Long-term survival of Streptococcus pneumoniae at room temperature on Dorset egg medium. J Clin Microbiol 1998; 36:1139–1140 [View Article] [PubMed]
     [Google Scholar]
  17. Austrian R, Gold J. Pneumococcal bacteriamia with special reference to bacterimic pneumococcal pneuminia. Ann Intern Med 1964; 60:759–776 [View Article] [PubMed]
     [Google Scholar]
  18. Wikler M, Cockerill F, Craig W, Dudley M, Eliopoulos G et al. Performance Standards for Antimicrobial Susceptibility Testing Seventeenth Informational Supplement. Clinical and Laboratory Standars Institute - NCCLS; 2020
     [Google Scholar]
  19. Ndlangisa KM, du Plessis M, Allam M, Wolter N, Mohale T et al. Two cases of serotypeable and non-serotypeable variants of Streptococcus pneumoniae detected simultaneously during invasive disease. BMC Microbiol 2016; 16:126 [View Article] [PubMed]
     [Google Scholar]
  20. Gladstone RA, Lo SW, Lees JA, Croucher NJ, van Tonder AJ et al. International genomic definition of pneumococcal lineages, to contextualise disease, antibiotic resistance and vaccine impact. EBioMedicine 2019; 43:338–346 [View Article] [PubMed]
     [Google Scholar]
  21. Metcalf BJ, Gertz RE Jr, Gladstone RA, Walker H, Sherwood LK et al. Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA. Clin Microbiol Infect 2016; 22:60 [View Article] [PubMed]
     [Google Scholar]
  22. Page AJ, De Silva N, Hunt M, Quail MA, Parkhill J et al. Robust high-throughput prokaryote de novo assembly and improvement pipeline for Illumina data. Microb Genom 2016; 2:e000083 [View Article] [PubMed]
     [Google Scholar]
  23. Epping L, van Tonder AJ, Gladstone RA, Bentley SD, Page AJ et al. SeroBA: rapid high-throughput serotyping of Streptococcus pneumoniae from whole genome sequence data. Microbial Genomics 2018; 4:1–6 [View Article]
     [Google Scholar]
  24. J. Page A, Taylor B, A. Keane J. Multilocus sequence typing by blast from de novo assemblies against PubMLST. JOSS 2016; 1:118 [View Article]
     [Google Scholar]
  25. Lees JA, Harris SR, Tonkin-Hill G, Gladstone RA, Lo SW et al. Fast and flexible bacterial genomic epidemiology with PopPUNK. Genome Res 2019; 29:304–316 [View Article]
     [Google Scholar]
  26. Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 2010; 26:589–595 [View Article] [PubMed]
     [Google Scholar]
  27. Stamatakis A. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics 2006; 22:2688–2690 [View Article] [PubMed]
     [Google Scholar]
  28. Hadfield J, Croucher NJ, Goater RJ, Abudahab K, Aanensen DM et al. Phandango: an interactive viewer for bacterial population genomics. Bioinformatics 2018; 34:292–293 [View Article] [PubMed]
     [Google Scholar]
  29. Croucher NJ, Page AJ, Connor TR, Delaney AJ, Keane JA et al. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res 2015; 43:e15 [View Article] [PubMed]
     [Google Scholar]
  30. Statistics South Africa Mid-year population estimates. n.d https://www.statssa.gov.za/?page_id=1866&PPN=P0302&SCH=74263)
  31. Lo SW, Gladstone RA, van Tonder AJ, Lees JA, du Plessis M et al. Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study. Lancet Infect Dis 2019; 19:759–769 [View Article] [PubMed]
     [Google Scholar]
  32. Ndlangisa KM, du Plessis M, Lo S, de Gouveia L, Chaguza C et al. A Streptococcus pneumoniae lineage usually associated with pneumococcal conjugate vaccine (PCV) serotypes is the most common cause of serotype 35B invasive disease in South Africa, following routine use of PCV. Microb Genom 2022; 8:1–10 [View Article] [PubMed]
     [Google Scholar]
  33. Kandasamy R, Lo S, Gurung M, Carter MJ, Gladstone R et al. Effect of childhood vaccination and antibiotic use on pneumococcal populations and genome-wide associations with disease among children in Nepal: an observational study. Lancet Microbe 2022; 3:e503–e511 [View Article] [PubMed]
     [Google Scholar]
  34. Yamba Yamba L, Uddén F, Fuursted K, Ahl J, Slotved HC et al. Extensive/multidrug-resistant pneumococci detected in clinical respiratory tract samples in southern Sweden are closely related to international multidrug-resistant lineages. Front Cell Infect Microbiol 2022; 12:824449 [View Article] [PubMed]
     [Google Scholar]
  35. Nagaraj G, Govindan V, Ganaie F, Venkatesha VT, Hawkins PA et al. Streptococcus pneumoniae genomic datasets from an Indian population describing pre-vaccine evolutionary epidemiology using a whole genome sequencing approach. Microb Genom 2021; 7:1–10 [View Article] [PubMed]
     [Google Scholar]
  36. Hawkins PA, Chochua S, Lo SW, Belman S, Antonio M et al. A global genomic perspective on the multidrug-resistant Streptococcus pneumoniae 15A-CC63 sub-lineage following pneumococcal conjugate vaccine introduction. Microb Genom 2023; 9:mgen000998 [View Article] [PubMed]
     [Google Scholar]
/content/journal/mgen/10.1099/mgen.0.001559
Loading
Population snapshot of Streptococcus pneumoniae causing invasive disease among adults aged ≥18 years in South Africa before and after implementation of pneumococcal conjugate vaccines in 2005–2020
M Gen 11, 001559 (2025); https://doi.org/10.1099/mgen.0.001559
/content/journal/mgen/10.1099/mgen.0.001559
/content/journal/mgen/10.1099/mgen.0.001559
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Supplementary material 2

EXCEL

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error